| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 410,8 k € | +9.1% | 376,6 k € | +18.7% | 317,2 k € | +1.8% | 311,6 k € | -24.4% | 412,4 k € | +16.7% | 353,5 k € | +4.3% | 338,9 k € | -1.3% | 343,4 k € | +8.7% | 315,9 k € | +29.5% | 243,9 k € | +47.9% | 164,9 k € | -10.0% | 183,3 k € | +15.0% | 159,5 k € | -25.8% | 214,9 k € | |
| EBITDA | 409,0 k € | +9.1% | 375,0 k € | +23.9% | 302,7 k € | -2.4% | 310,1 k € | -24.2% | 409,1 k € | +16.6% | 350,9 k € | +4.2% | 336,7 k € | -1.5% | 341,7 k € | +8.5% | 315,0 k € | +29.7% | 242,9 k € | +48.3% | 163,8 k € | -10.3% | 182,5 k € | +15.0% | 158,7 k € | -25.8% | 213,9 k € | |
| Operating profit | 400,6 k € | +7.4% | 372,9 k € | +24.1% | 300,5 k € | -2.0% | 306,6 k € | -24.1% | 403,9 k € | +19.5% | 338,0 k € | +4.4% | 323,7 k € | -2.2% | 331,0 k € | +6.3% | 311,3 k € | +31.6% | 236,5 k € | +48.3% | 159,5 k € | -10.6% | 178,3 k € | +15.5% | 154,4 k € | -25.9% | 208,5 k € | |
| Profit/loss | 324,6 k € | +19.6% | 271,5 k € | +17.3% | 231,4 k € | -5.2% | 244,0 k € | -12.8% | 279,7 k € | +24.8% | 224,1 k € | +15.1% | 194,7 k € | -4.7% | 204,3 k € | +21.3% | 168,4 k € | +17.1% | 143,9 k € | +32.6% | 108,5 k € | -9.2% | 119,5 k € | +16.9% | 102,2 k € | -25.5% | 137,2 k € | |
| Equity | 1,4 M € | +4.1% | 1,3 M € | -0.6% | 1,3 M € | +0.5% | 1,3 M € | +3.9% | 1,3 M € | +7.7% | 1,2 M € | +23.6% | 947,8 k € | +25.8% | 753,1 k € | +37.2% | 548,8 k € | +44.3% | 380,4 k € | +41.0% | 269,9 k € | +67.3% | 161,3 k € | +285.8% | 41,8 k € | +5.7% | 39,6 k € | |
| Total assets | 1,7 M € | +5.9% | 1,6 M € | +4.1% | 1,6 M € | +2.1% | 1,5 M € | +2.9% | 1,5 M € | +22.5% | 1,2 M € | +22.3% | 987,1 k € | +19.7% | 825,0 k € | +30.0% | 634,7 k € | +43.0% | 443,9 k € | +59.9% | 277,6 k € | +64.8% | 168,4 k € | +26.5% | 133,2 k € | -14.6% | 155,9 k € | |
| Cash | 122,9 k € | -45.4% | 225,2 k € | +15.7% | 194,6 k € | -54.5% | 427,4 k € | -3.1% | 441,2 k € | +1.5% | 434,7 k € | +32.0% | 329,4 k € | +18.2% | 278,7 k € | +53.7% | 181,3 k € | -32.7% | 269,3 k € | +73.2% | 155,5 k € | +109.4% | 74,3 k € | -5.8% | 78,8 k € | +3.0% | 76,5 k € | |
| Debts | 346,9 k € | +13.4% | 305,9 k € | +31.7% | 232,3 k € | +10.6% | 210,1 k € | -3.2% | 217,1 k € | +494.5% | 36,5 k € | -7.1% | 39,3 k € | -45.3% | 71,8 k € | -16.4% | 85,9 k € | +35.3% | 63,5 k € | +723.8% | 7,7 k € | +9.0% | 7,1 k € | -92.3% | 91,4 k € | -21.5% | 116,3 k € | |
Private limited company · Holsbeek · incorporated on 27/01/2010
Private limited company profitable and well capitalised. Cash position declining (-45.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. KAREN DERAEDT is a Private limited company incorporated in 2010. Its registered office is in Holsbeek.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette